You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Pharma & Healthcare

Global Large Volume Parenterals (LVP) Market Insights and Forecast to 2026

Market Analysis and Insights: Global Large Volume Parenterals (LVP) Market
Prior to COVID-19, the market for Large Volume Parenterals (LVP) was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of XX% during 2021–2026, whereas post-COVID-19 scenario, the market for Large Volume Parenterals (LVP) is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Large Volume Parenterals (LVP) market.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Large Volume Parenterals (LVP) market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Large Volume Parenterals (LVP) industry.
Global Large Volume Parenterals (LVP) Scope and Segment
Large Volume Parenterals (LVP) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Large Volume Parenterals (LVP) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
The following manufacturers are covered in this report:
Ostuka Pharmaceutical (Japan)
Teva Pharmaceutical Industries Limited (Israel)
Kelun Pharma (China)
Cook Pharmica LLC (Catalent) (US)
Patheon Inc. (Netherlands)
BAG Healthcare (Germany)
Southwest Pharmaceutical Co. Ltd. (China)
Beximco Pharma (Bangladesh)
Baxter Healthcare Corporation (US)
Large Volume Parenterals (LVP) Breakdown Data by Type
Fluid Balance Injections
Therapeutic Injections
Nutritious Injections
Large Volume Parenterals (LVP) Breakdown Data by Application
Intravenous
Intramuscular
Subcutaneous
Others
Regional and Country-level Analysis
The Large Volume Parenterals (LVP) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Large Volume Parenterals (LVP) market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Large Volume Parenterals (LVP) Market Share Analysis
1 Study Coverage
1.1 Large Volume Parenterals (LVP) Product Introduction
1.2 Market Segments
1.3 Key Large Volume Parenterals (LVP) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Large Volume Parenterals (LVP) Market Size Growth Rate by Type
1.4.2 Fluid Balance Injections
1.4.3 Therapeutic Injections
1.4.4 Nutritious Injections
1.5 Market by Application
1.5.1 Global Large Volume Parenterals (LVP) Market Size Growth Rate by Application
1.5.2 Intravenous
1.5.3 Intramuscular
1.5.4 Subcutaneous
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Large Volume Parenterals (LVP) Market Size, Estimates and Forecasts
2.1.1 Global Large Volume Parenterals (LVP) Revenue 2015-2026
2.1.2 Global Large Volume Parenterals (LVP) Sales 2015-2026
2.2 Global Large Volume Parenterals (LVP), Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Large Volume Parenterals (LVP) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Large Volume Parenterals (LVP) Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Large Volume Parenterals (LVP) Competitor Landscape by Players
3.1 Large Volume Parenterals (LVP) Sales by Manufacturers
3.1.1 Large Volume Parenterals (LVP) Sales by Manufacturers (2015-2020)
3.1.2 Large Volume Parenterals (LVP) Sales Market Share by Manufacturers (2015-2020)
3.2 Large Volume Parenterals (LVP) Revenue by Manufacturers
3.2.1 Large Volume Parenterals (LVP) Revenue by Manufacturers (2015-2020)
3.2.2 Large Volume Parenterals (LVP) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Large Volume Parenterals (LVP) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Large Volume Parenterals (LVP) Revenue in 2019
3.2.5 Global Large Volume Parenterals (LVP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Large Volume Parenterals (LVP) Price by Manufacturers
3.4 Large Volume Parenterals (LVP) Manufacturing Base Distribution, Product Types
3.4.1 Large Volume Parenterals (LVP) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Large Volume Parenterals (LVP) Product Type
3.4.3 Date of International Manufacturers Enter into Large Volume Parenterals (LVP) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Large Volume Parenterals (LVP) Market Size by Type (2015-2020)
4.1.1 Global Large Volume Parenterals (LVP) Sales by Type (2015-2020)
4.1.2 Global Large Volume Parenterals (LVP) Revenue by Type (2015-2020)
4.1.3 Large Volume Parenterals (LVP) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Large Volume Parenterals (LVP) Market Size Forecast by Type (2021-2026)
4.2.1 Global Large Volume Parenterals (LVP) Sales Forecast by Type (2021-2026)
4.2.2 Global Large Volume Parenterals (LVP) Revenue Forecast by Type (2021-2026)
4.2.3 Large Volume Parenterals (LVP) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Large Volume Parenterals (LVP) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Large Volume Parenterals (LVP) Market Size by Application (2015-2020)
5.1.1 Global Large Volume Parenterals (LVP) Sales by Application (2015-2020)
5.1.2 Global Large Volume Parenterals (LVP) Revenue by Application (2015-2020)
5.1.3 Large Volume Parenterals (LVP) Price by Application (2015-2020)
5.2 Large Volume Parenterals (LVP) Market Size Forecast by Application (2021-2026)
5.2.1 Global Large Volume Parenterals (LVP) Sales Forecast by Application (2021-2026)
5.2.2 Global Large Volume Parenterals (LVP) Revenue Forecast by Application (2021-2026)
5.2.3 Global Large Volume Parenterals (LVP) Price Forecast by Application (2021-2026)

6 North America
6.1 North America Large Volume Parenterals (LVP) by Country
6.1.1 North America Large Volume Parenterals (LVP) Sales by Country
6.1.2 North America Large Volume Parenterals (LVP) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Large Volume Parenterals (LVP) Market Facts & Figures by Type
6.3 North America Large Volume Parenterals (LVP) Market Facts & Figures by Application

7 Europe
7.1 Europe Large Volume Parenterals (LVP) by Country
7.1.1 Europe Large Volume Parenterals (LVP) Sales by Country
7.1.2 Europe Large Volume Parenterals (LVP) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Large Volume Parenterals (LVP) Market Facts & Figures by Type
7.3 Europe Large Volume Parenterals (LVP) Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Large Volume Parenterals (LVP) by Region
8.1.1 Asia Pacific Large Volume Parenterals (LVP) Sales by Region
8.1.2 Asia Pacific Large Volume Parenterals (LVP) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Large Volume Parenterals (LVP) Market Facts & Figures by Type
8.3 Asia Pacific Large Volume Parenterals (LVP) Market Facts & Figures by Application

9 Latin America
9.1 Latin America Large Volume Parenterals (LVP) by Country
9.1.1 Latin America Large Volume Parenterals (LVP) Sales by Country
9.1.2 Latin America Large Volume Parenterals (LVP) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Large Volume Parenterals (LVP) Market Facts & Figures by Type
9.3 Central & South America Large Volume Parenterals (LVP) Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Large Volume Parenterals (LVP) by Country
10.1.1 Middle East and Africa Large Volume Parenterals (LVP) Sales by Country
10.1.2 Middle East and Africa Large Volume Parenterals (LVP) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Large Volume Parenterals (LVP) Market Facts & Figures by Type
10.3 Middle East and Africa Large Volume Parenterals (LVP) Market Facts & Figures by Application

11 Company Profiles
11.1 Ostuka Pharmaceutical (Japan)
11.1.1 Ostuka Pharmaceutical (Japan) Corporation Information
11.1.2 Ostuka Pharmaceutical (Japan) Description and Business Overview
11.1.3 Ostuka Pharmaceutical (Japan) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Ostuka Pharmaceutical (Japan) Large Volume Parenterals (LVP) Products Offered
11.1.5 Ostuka Pharmaceutical (Japan) Related Developments
11.2 Teva Pharmaceutical Industries Limited (Israel)
11.2.1 Teva Pharmaceutical Industries Limited (Israel) Corporation Information
11.2.2 Teva Pharmaceutical Industries Limited (Israel) Description and Business Overview
11.2.3 Teva Pharmaceutical Industries Limited (Israel) Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Teva Pharmaceutical Industries Limited (Israel) Large Volume Parenterals (LVP) Products Offered
11.2.5 Teva Pharmaceutical Industries Limited (Israel) Related Developments
11.3 Kelun Pharma (China)
11.3.1 Kelun Pharma (China) Corporation Information
11.3.2 Kelun Pharma (China) Description and Business Overview
11.3.3 Kelun Pharma (China) Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Kelun Pharma (China) Large Volume Parenterals (LVP) Products Offered
11.3.5 Kelun Pharma (China) Related Developments
11.4 Cook Pharmica LLC (Catalent) (US)
11.4.1 Cook Pharmica LLC (Catalent) (US) Corporation Information
11.4.2 Cook Pharmica LLC (Catalent) (US) Description and Business Overview
11.4.3 Cook Pharmica LLC (Catalent) (US) Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Cook Pharmica LLC (Catalent) (US) Large Volume Parenterals (LVP) Products Offered
11.4.5 Cook Pharmica LLC (Catalent) (US) Related Developments
11.5 Patheon Inc. (Netherlands)
11.5.1 Patheon Inc. (Netherlands) Corporation Information
11.5.2 Patheon Inc. (Netherlands) Description and Business Overview
11.5.3 Patheon Inc. (Netherlands) Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Patheon Inc. (Netherlands) Large Volume Parenterals (LVP) Products Offered
11.5.5 Patheon Inc. (Netherlands) Related Developments
11.6 BAG Healthcare (Germany)
11.6.1 BAG Healthcare (Germany) Corporation Information
11.6.2 BAG Healthcare (Germany) Description and Business Overview
11.6.3 BAG Healthcare (Germany) Sales, Revenue and Gross Margin (2015-2020)
11.6.4 BAG Healthcare (Germany) Large Volume Parenterals (LVP) Products Offered
11.6.5 BAG Healthcare (Germany) Related Developments
11.7 Southwest Pharmaceutical Co. Ltd. (China)
11.7.1 Southwest Pharmaceutical Co. Ltd. (China) Corporation Information
11.7.2 Southwest Pharmaceutical Co. Ltd. (China) Description and Business Overview
11.7.3 Southwest Pharmaceutical Co. Ltd. (China) Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Southwest Pharmaceutical Co. Ltd. (China) Large Volume Parenterals (LVP) Products Offered
11.7.5 Southwest Pharmaceutical Co. Ltd. (China) Related Developments
11.8 Beximco Pharma (Bangladesh)
11.8.1 Beximco Pharma (Bangladesh) Corporation Information
11.8.2 Beximco Pharma (Bangladesh) Description and Business Overview
11.8.3 Beximco Pharma (Bangladesh) Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Beximco Pharma (Bangladesh) Large Volume Parenterals (LVP) Products Offered
11.8.5 Beximco Pharma (Bangladesh) Related Developments
11.9 Baxter Healthcare Corporation (US)
11.9.1 Baxter Healthcare Corporation (US) Corporation Information
11.9.2 Baxter Healthcare Corporation (US) Description and Business Overview
11.9.3 Baxter Healthcare Corporation (US) Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Baxter Healthcare Corporation (US) Large Volume Parenterals (LVP) Products Offered
11.9.5 Baxter Healthcare Corporation (US) Related Developments
11.1 Ostuka Pharmaceutical (Japan)
11.1.1 Ostuka Pharmaceutical (Japan) Corporation Information
11.1.2 Ostuka Pharmaceutical (Japan) Description and Business Overview
11.1.3 Ostuka Pharmaceutical (Japan) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Ostuka Pharmaceutical (Japan) Large Volume Parenterals (LVP) Products Offered
11.1.5 Ostuka Pharmaceutical (Japan) Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Large Volume Parenterals (LVP) Market Estimates and Projections by Region
12.1.1 Global Large Volume Parenterals (LVP) Sales Forecast by Regions 2021-2026
12.1.2 Global Large Volume Parenterals (LVP) Revenue Forecast by Regions 2021-2026
12.2 North America Large Volume Parenterals (LVP) Market Size Forecast (2021-2026)
12.2.1 North America: Large Volume Parenterals (LVP) Sales Forecast (2021-2026)
12.2.2 North America: Large Volume Parenterals (LVP) Revenue Forecast (2021-2026)
12.2.3 North America: Large Volume Parenterals (LVP) Market Size Forecast by Country (2021-2026)
12.3 Europe Large Volume Parenterals (LVP) Market Size Forecast (2021-2026)
12.3.1 Europe: Large Volume Parenterals (LVP) Sales Forecast (2021-2026)
12.3.2 Europe: Large Volume Parenterals (LVP) Revenue Forecast (2021-2026)
12.3.3 Europe: Large Volume Parenterals (LVP) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Large Volume Parenterals (LVP) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Large Volume Parenterals (LVP) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Large Volume Parenterals (LVP) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Large Volume Parenterals (LVP) Market Size Forecast by Region (2021-2026)
12.5 Latin America Large Volume Parenterals (LVP) Market Size Forecast (2021-2026)
12.5.1 Latin America: Large Volume Parenterals (LVP) Sales Forecast (2021-2026)
12.5.2 Latin America: Large Volume Parenterals (LVP) Revenue Forecast (2021-2026)
12.5.3 Latin America: Large Volume Parenterals (LVP) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Large Volume Parenterals (LVP) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Large Volume Parenterals (LVP) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Large Volume Parenterals (LVP) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Large Volume Parenterals (LVP) Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Large Volume Parenterals (LVP) Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Large Volume Parenterals (LVP) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
  • FORMAT: PDF
  • PUBLISHED DATE: Jul, 2020
  • NO OF PAGES: 134